专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US06177414B1 Starburst conjugates 失效
标题翻译：星爆共轭体
公开(公告)号：US06177414B1
公开(公告)日：2001-01-23
申请号：US09521409
申请日：2000-03-08
申请人： Donald A. Tomalia , William J. Kruper , Roberta C. Cheng , Ian A. Tomlinson , Michael J. Fazio , David M. Hedstrand , Larry R. Wilson , Donald A. Kaplan
发明人： Donald A. Tomalia , William J. Kruper , Roberta C. Cheng , Ian A. Tomlinson , Michael J. Fazio , David M. Hedstrand , Larry R. Wilson , Donald A. Kaplan
IPC分类号： A61K3160
CPC分类号： A01N25/10 , A61K47/59 , A61K47/6885 , A61K47/6949 , B82Y5/00 , C07C211/29 , C07C233/11 , C07C237/20 , C08G73/02 , C08G83/003 , C08L101/005 , C12N15/87 , Y10S424/16
摘要： Starburst conjugates which are composed of at least one dendrimer in association with at least one unit of a carried agricultural, pharmaceutical, or other material have been prepared. These conjugates have particularly advantageous properties due to the unique characteristics of the dendrimer.
摘要翻译：已经制备了由至少一种树枝状大分子与携带的农业，药物或其它材料的至少一个单元组合的星状共轭体。由于树枝状聚合物的独特特征，这些共轭物具有特别有利的性质。

2. 发明授权

US5527524A Dense star polymer conjugates 失效
标题翻译：密集聚合物共轭物
公开(公告)号：US5527524A
公开(公告)日：1996-06-18
申请号：US43198
申请日：1993-04-05
申请人： Donald A. Tomalia , Larry R. Wilson , David M. Hedstrand , Ian A. Tomlinson , Michael J. Fazio , William J. Kruper, Jr. , Donald A. Kaplan , Roberta C. Cheng , David S. Edwards , Chu W. Jung
发明人： Donald A. Tomalia , Larry R. Wilson , David M. Hedstrand , Ian A. Tomlinson , Michael J. Fazio , William J. Kruper, Jr. , Donald A. Kaplan , Roberta C. Cheng , David S. Edwards , Chu W. Jung
IPC分类号： A01N25/10 , A61K47/48 , C07C211/29 , C07C233/11 , C07C237/20 , C08G73/02 , C08G83/00 , C08L101/00 , C12N15/87 , A61K31/74 , A61K9/14 , A61K31/785
CPC分类号： A01N25/10 , A61K47/48192 , A61K47/48207 , A61K47/487 , A61K47/48961 , B82Y5/00 , C07C211/29 , C07C233/11 , C07C237/20 , C08G73/02 , C08G83/003 , C08L101/005 , C12N15/87 , Y10S424/16
摘要： Dense star polymer conjugates which are composed of at least one dendrimer in association with at least one unit of a carried agricultural, pharmaceutical, or other material have been prepared. These conjugates have particularly advantageous properties due to the unique characteristics of the dendrimer.
摘要翻译：已经制备了由携带的农业，药物或其它材料的至少一个单元组成的至少一个树枝状大分子组成的密集聚合物共轭物。由于树枝状聚合物的独特特征，这些共轭物具有特别有利的性质。

3. 发明授权

US4151065A Horizontal slab gel electrophoresis 失效
标题翻译：水平平板凝胶电泳
公开(公告)号：US4151065A
公开(公告)日：1979-04-24
申请号：US873448
申请日：1978-01-30
申请人： Donald A. Kaplan , Gary L. Wilcox
发明人： Donald A. Kaplan , Gary L. Wilcox
IPC分类号： G01N27/447 , G01N27/26 , G01N27/28
CPC分类号： G01N27/44756
摘要： An improved horizontal slab gel electrophoresis apparatus having compartments for vertical wicks at each end of a removable horizontal trough. Adjacent to the vertical wicks are vertical buffer compartments with built in electrodes. A partition separates the vertical wirks from the buffer compartment and includes a slot with a silicone plug which can be removed after curing or hardening of the vertical wicks to permit communication between the buffer and the gel slab. Flow adapters and an interconnecting tube permit constant circulation of the buffer to maintain equal volume and pH. The horizontal trough has slots for insertion of combs to form up to seventy-five sample wells and additional slots at each end for sealing the end of the horizontal slab when the gel slab is removed. The apparatus includes coils in a horizontal bed or plate beneath the trough for cooling the gel slab during a run and levelling screws for levelling the horizontal trough before pouring the gel slab.
摘要翻译：一种改进的水平平板凝胶电泳装置，其具有在可移除的水平槽的每一端处用于垂直芯的隔室。与垂直灯芯相邻的是内置电极的垂直缓冲隔间。隔板将垂直织带与缓冲隔间分开，并且包括具有硅胶塞的槽，其可以在固化或硬化垂直芯之后被去除，以允许缓冲器和凝胶板之间的连通。流动适配器和互连管允许缓冲液的恒定循环以保持相等的体积和pH。水平槽具有用于插入梳子以形成多达七十五个样品孔的槽，并且在每个端部具有另外的槽，用于在去除凝胶板时密封水平板的端部。该设备包括在槽下面的水平床或板中的线圈，用于在运行期间冷却凝胶板，并且在调整螺钉之前，在浇注凝胶板之前调平水平槽。

4. 发明授权

US4853209A Bone marrow suppressing agents 失效
标题翻译：骨髓抑制剂
公开(公告)号：US4853209A
公开(公告)日：1989-08-01
申请号：US114275
申请日：1987-10-27
申请人： Donald A. Kaplan , William F. Goeckeler
发明人： Donald A. Kaplan , William F. Goeckeler
IPC分类号： A61K51/04
CPC分类号： A61K51/0489 , A61K51/0478 , A61K2121/00
摘要： The invention concerns a method for suppressing bone marrow which comprises administering at least one bone marrow suppressing radionuclide composition selected from the group of radionuclide compositions comprised of at least one of Samarium-153, Gadolinium-519, and Holmium-166 and at least one of ethylenediaminetetramethylenephosphonic acid, diethylenetriaminepentamethylenephosphonic acid, hydroxyethylethylenediaminetrimethylenephosphonic acid, nitrilotrimethylenephosphonic acid and tris(2-aminoethyl)aminehexamethylenephosphonic acid, or a physiologically acceptable salt thereof.
摘要翻译：本发明涉及一种抑制骨髓的方法，其包括施用至少一种选自由钐-153，钆-519和钬-166中的至少一种组成的放射性核素组合物的骨髓抑制放射性核素组合物和至少一种乙二胺四亚甲基膦酸，二亚乙基三胺五亚甲基膦酸，羟乙基乙二胺三亚甲基膦酸，次氮基三亚甲基膦酸和三（2-氨基乙基）胺六亚甲基膦酸或其生理学上可接受的盐。

5. 发明授权

US4234400A Horizontal slab gel electrophoresis 失效
标题翻译：水平平板凝胶电泳
公开(公告)号：US4234400A
公开(公告)日：1980-11-18
申请号：US6826
申请日：1979-01-26
申请人： Donald A. Kaplan , Gary L. Wilcox
发明人： Donald A. Kaplan , Gary L. Wilcox
IPC分类号： G01N27/447 , G01N27/26 , G01N27/28
CPC分类号： G01N27/44782 , G01N27/44756
摘要： An improved horizontal slab gel electrophoresis apparatus having compartments for vertical wicks at each end of a removable horizontal trough. Adjacent to the vertical wicks are vertical buffer compartments with built in electrodes. A partition separates the vertical wicks from the buffer compartment and includes a slot with a silicone plug which can be removed after curing or hardening of the vertical wicks to permit communication between the buffer and the gel slab. Flow adapters and an interconnecting tube permit constant circulation of the buffer to maintain equal volume and pH. The horizontal trough has slots for insertion of combs to form up to seventy-five sample wells and additional slots at each end for sealing the end of the horizontal slab when the gel slab is removed. The apparatus includes coils in a horizontal bed or plate beneath the trough for cooling the gel slab during a run and levelling screws for levelling the horizontal trough before pouring the gel slab.
摘要翻译：一种改进的水平平板凝胶电泳装置，其具有在可移除的水平槽的每一端处用于垂直芯的隔室。与垂直灯芯相邻的是内置电极的垂直缓冲隔间。隔板将垂直芯与缓冲隔间分开，并且包括具有硅胶塞的槽，其可以在固化或硬化垂直芯之后被去除以允许缓冲器和凝胶板之间的连通。流动适配器和互连管允许缓冲液的恒定循环以保持相等的体积和pH。水平槽具有用于插入梳子以形成多达七十五个样品孔的槽，并且在每个端部具有另外的槽，用于在去除凝胶板时密封水平板的端部。该设备包括在槽下面的水平床或板中的线圈，用于在运行期间冷却凝胶板，并且在调整螺钉之前，在浇注凝胶板之前调平水平槽。

6. 发明授权

US5714166A Bioactive and/or targeted dendrimer conjugates 失效
标题翻译：生物活性和/或靶向树枝状大分子缀合物
公开(公告)号：US5714166A
公开(公告)日：1998-02-03
申请号：US400203
申请日：1995-03-07
申请人： Donald A. Tomalia , James R. Baker , Roberta C. Cheng , Anna U. Bielinska , Michael J. Fazio , David M. Hedstrand , Jennifer A. Johnson , Donald A. Kaplan, deceased , Scott L. Klakamp , William J. Kruper, Jr. , Jolanta Kukowska-Latallo , Bartley D. Maxon , Lars T. Piehler , Ian A. Tomlinson , Larry R. Wilson , Rui Yin , Herbert M. Brothers, II
发明人： Donald A. Tomalia , James R. Baker , Roberta C. Cheng , Anna U. Bielinska , Michael J. Fazio , David M. Hedstrand , Jennifer A. Johnson , Donald A. Kaplan, deceased , Scott L. Klakamp , William J. Kruper, Jr. , Jolanta Kukowska-Latallo , Bartley D. Maxon , Lars T. Piehler , Ian A. Tomlinson , Larry R. Wilson , Rui Yin , Herbert M. Brothers, II
IPC分类号： C12N15/02 , A01N25/10 , A61K20060101 , A61K31/70 , A61K38/00 , A61K39/385 , A61K39/44 , A61K45/00 , A61K47/34 , A61K47/48 , A61K48/00 , A61K49/00 , A61K51/00 , C07C211/29 , C07C233/11 , C07C237/20 , C07K20060101 , C07K14/525 , C07K14/535 , C07K14/54 , C07K14/555 , C07K17/06 , C07K17/08 , C08G73/00 , C08G83/00 , C08L101/00 , C12N20060101 , C12N5/10 , C12N15/09 , C12N15/57 , C12N15/87 , C12P21/02 , C12P21/08 , C12R1/91 , A61K31/74 , A61K9/14 , A61K31/785
CPC分类号： A01N25/10 , A61K47/48192 , A61K47/48207 , A61K47/4823 , A61K47/48961 , A61K49/085 , A61K49/124 , B82Y5/00 , C07C211/29 , C07C233/11 , C07C237/20 , C08G83/003 , C08L101/005 , C12N15/87 , Y10S424/16
摘要： Dendritic polymer conjugates which are composed of at least one dendrimer in association with at least one unit of a carried material, where the carrier material can be a biological response modifier, have been prepared. The conjugate can also have a target director present, and when it is present then the carried material may be a bioactive agent. Preferred dendritic polymers are dense star polymers, which have been complexed with biological response modifiers. These conjugates and complexes have particularly advantageous properties due to their unique characteristics.
摘要翻译：已经制备了由载体材料可以是生物反应调节剂的至少一种携带材料的至少一个单元组成的树枝状聚合物共轭物。缀合物还可以存在目标导向剂，并且当其存在时，所携带的材料可以是生物活性剂。优选的树枝状聚合物是与生物反应调节剂复合的致密星形聚合物。这些共轭物和配合物由于其独特的特性而具有特别有利的性质。

7. 发明授权

US4603105A Efficient screening methods for low probability variants 失效
标题翻译：低概率变异的有效筛选方法
公开(公告)号：US4603105A
公开(公告)日：1986-07-29
申请号：US382843
申请日：1982-05-27
申请人： Donald A. Kaplan
发明人： Donald A. Kaplan
IPC分类号： C12M1/12 , C12Q1/04 , G01N33/558 , C12Q1/00 , C12M1/16 , C12M1/18
CPC分类号： C12Q1/04 , G01N33/558 , Y10S435/81
摘要： Rapid screening of a large number of organisms for variants producing particular products is accomplished using membrane plates having a predetermined molecular weight cutoff and which divide a container into two chambers. High density cellular lawns are employed in conjunction with labeled antibodies for the product of interest mixed in soft agar. The cells are subjected to viral lysis and after the plaques have reached maturity, the plates are immersed in buffer. Residual soluble labeled antibody diffuses from the agar, and immunoprecipitate of the product and the antibody may then be detected.
摘要翻译：使用具有预定分子量截留值的膜板并且将容器分成两个室来实现用于产生特定产品的变体的大量生物体的快速筛选。与软琼脂中混合的感兴趣的产品的标记抗体结合使用高密度细胞草坪。细胞经历病毒裂解，斑块达到成熟后，将板浸入缓冲液中。残留可溶性标记抗体从琼脂扩散，然后可以检测产物和抗体的免疫沉淀物。

8. 发明授权

US06207815B1 Family of high affinity, modified antibodies for cancer treatment 失效
标题翻译：高亲和力家族，用于癌症治疗的修饰抗体
公开(公告)号：US06207815B1
公开(公告)日：2001-03-27
申请号：US08479285
申请日：1995-06-07
申请人： Peter S. Mezes , Brian B. Gourlie , Mark W. Rixon , Jeffrey Schlom , Donald A. Kaplan , W. H. Kerr Anderson
发明人： Peter S. Mezes , Brian B. Gourlie , Mark W. Rixon , Jeffrey Schlom , Donald A. Kaplan , W. H. Kerr Anderson
IPC分类号： C12N1514
CPC分类号： C07K16/462 , A61K38/00 , A61K47/6877 , A61K51/1087 , A61K2123/00 , C07K16/30 , C07K2317/24 , C07K2319/00
摘要： This invention concerns a family of chimeric antibodies with high affinities to a high molecular weight, tumor-associated sialylated glycoprotein antigen (TAG-72) of human origin. These antibodies have (1) high affinity animal VH and VL sequences which mediate TAG-72 binding and (2) human CH and CL regions. They are thought to produce significantly fewer side-effects when administered to human patients by virtue of their human CH and CL antibody domains. The nucleotide and amino acid sequences of VH&agr;TAG VH, CC46 VH, CC49H, CC83 VH, and CC92 VH, and CC49L, CC83 VL, and CC92 VL idiotype sequences are disclosed, as well as in vivo methods of treatment and diagnostic assay using these chimeric antibodies.
摘要翻译：本发明涉及对人类高分子量肿瘤相关唾液酸化糖蛋白抗原（TAG-72）具有高亲和力的嵌合抗体家族。这些抗体具有（1）介导TAG-72结合的高亲和力动物VH和VL序列，（2）人CH和CL区。据认为，由于其人类CH和CL抗体结构域，当向人类患者施用时，它们会产生显着较少的副作用。公开了VHαphaVV，CC46VH，CC49H，CC83VV和CC92VV，CC49L，CC83VL和CC92VV独立型序列的核苷酸和氨基酸序列，以及使用这些嵌合体的体内治疗和诊断测定方法抗体。

9. 发明授权

US5993813A Family of high affinity, modified antibodies for cancer treatment 失效
公开(公告)号：US5993813A
公开(公告)日：1999-11-30
申请号：US822028
申请日：1997-03-24
申请人： Peter S. Mezes , Brian B. Gourlie , Mark W. Rixon , Jeffrey Schlom , Donald A. Kaplan , W. H. Kerr Anderson
发明人： Peter S. Mezes , Brian B. Gourlie , Mark W. Rixon , Jeffrey Schlom , Donald A. Kaplan , W. H. Kerr Anderson
IPC分类号： A61K38/00 , A61K47/48 , A61K51/10 , A61P35/00 , C07K16/30 , C07K16/46 , C12N15/14 , C12P21/08 , A61K39/395
CPC分类号： A61K47/48669 , A61K51/1087 , C07K16/30 , C07K16/462 , A61K2123/00 , A61K38/00 , C07K2317/24 , C07K2319/00
摘要： This invention concerns a family of chimeric antibodies with high affinities to a high molecular weight, tumor-associated sialylated glycoprotein antigen (TAG-72) of human origin. These antibodies have (1) high affinity animal V.sub.H and V.sub.L sequences which mediate TAG-72 binding and (2) human C.sub.H and C.sub.L regions. They are thought to produce significantly fewer side-effects when administered to human patients by virtue of their human C.sub.H and C.sub.L antibody domains. The nucleotide and amino acid sequences of V.sub.H .alpha.TAG V.sub.H, CC46 V.sub.H, CC49.sub.H, CC83 V.sub.H, and CC92 V.sub.H, and CC49.sub.L, CC83 V.sub.L, and CC92 V.sub.L idiotype sequences are disclosed, as well as in vivo methods of treatment and diagnostic assay using these chimeric antibodies.

10. 发明授权

US5525633A Triaryl-ethylene derivatives 失效
标题翻译：三芳基 - 乙烯衍生物
公开(公告)号：US5525633A
公开(公告)日：1996-06-11
申请号：US259797
申请日：1994-06-15
申请人： Donald P. Matthews , Alan J. Bitonti , William A. Van Sickle , Donald A. Kaplan
发明人： Donald P. Matthews , Alan J. Bitonti , William A. Van Sickle , Donald A. Kaplan
IPC分类号： C07C217/20 , C07D295/092 , A61K31/135 , C07C211/28
CPC分类号： C07D295/088 , C07C217/20 , Y10S514/824
摘要： The present invention relates to novel triaryl-ethylene derivatives that are useful as anti-neoplastic agents, antiatherosclerotic agents, and hypocholesterolemic agents.
摘要翻译：本发明涉及可用作抗肿瘤剂，抗动脉粥样硬化剂和降血胆固醇剂的新型三芳基 - 乙烯衍生物。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式